Cargando…

A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study

BACKGROUND: A clinical diagnosis of polycystic ovary syndrome (PCOS) can be tedious with many different required tests and examinations. Furthermore, women with PCOS have increased risks for several metabolic complications, which need long-term health management. Therefore, we attempted to establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huiyu, Feng, Guoshuang, Alpadi, Kannan, Han, Yong, Yang, Rui, Chen, Lixue, Li, Rong, Qiao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970043/ https://www.ncbi.nlm.nih.gov/pubmed/35370993 http://dx.doi.org/10.3389/fendo.2022.821368

Ejemplares similares

An online tool for predicting ovarian reserve based on AMH level and age: A retrospective cohort study
por: Han, Yong, et al.
Publicado: (2022)

PCOCheck AMH ELISA: A Clinical Case Report to Resolve Miss-Matched Antral Follicle Counts (AFC) to Serum AMH
por: Kumar, Ajay, et al.
Publicado: (2021)

An Online Tool Using Basal or Activated Ovarian Reserve Markers to Predict the Number of Oocytes Retrieved Following Controlled Ovarian Stimulation: A Prospective Observational Cohort Study
por: Han, Yong, et al.
Publicado: (2022)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome
por: Abbara, Ali, et al.
Publicado: (2019)

SAT-016 Analytical Performance and Clinical Value of AMH Testing
por: Sluss, Patrick M, et al.
Publicado: (2020)

An online tool for predicting ovarian responses in unselected patients using dynamic inhibin B and basal antimüllerian hormone levels
por: Ma, Congcong, et al.
Publicado: (2023)

Serum Thyrotropin and Phase of the Menstrual Cycle
por: Benvenga, Salvatore, et al.
Publicado: (2017)

Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
por: Dumesic, Daniel A, et al.
Publicado: (2021)

Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age
por: Robertson, David M., et al.
Publicado: (2020)

MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients
por: Moolhuijsen, Loes, et al.
Publicado: (2019)

Clinical Application of AMH Measurement in Assisted Reproduction
por: Li, Hang Wun Raymond, et al.
Publicado: (2020)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

SAT-029 AMH Is Higher Across the Menstrual Cycle in Early Post-Menarchal Girls Than in Ovulatory Women
por: Ortega, Madison T, et al.
Publicado: (2020)

Association Between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome
por: Yu, Ting, et al.
Publicado: (2021)

Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH
por: Mohammad, Majid Bani, et al.
Publicado: (2017)

Ethnicity/Race and Age-Specific Variations of Serum AMH in Women—A Review
por: Kotlyar, Alexander M., et al.
Publicado: (2021)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome
por: Peng, Yuanyuan, et al.
Publicado: (2022)

Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
por: Tian, Ye, et al.
Publicado: (2023)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Serum Concentrations of GDF9 and BMP15 Across the Menstrual Cycle
por: Riepsamen, Angelique Helena, et al.
Publicado: (2021)

The relationships of sex hormone‐binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

Serum Trace Elements in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Yin, Jiechen, et al.
Publicado: (2020)

Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome
por: Zhang, Yuqin, et al.
Publicado: (2022)

Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome
por: Yang, Wan, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome
por: Czeczuga-Semeniuk, Ewa, et al.
Publicado: (2014)

Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
por: Li, Youran, et al.
Publicado: (2022)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome
por: Chen, Peipei, et al.
Publicado: (2022)

SAT-258 Anti-Mullerian Hormone (AMH) Levels Reflect Ovarian Follicle Count by MRI but Not Ovarian Size in Young Patients with Polycystic Ovary Syndrome
por: Pereira-Eshraghi, Camila, et al.
Publicado: (2019)

Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk
por: Gao, Rui, et al.
Publicado: (2022)

Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women With Different Polycystic Ovary Syndrome Phenotypes
por: Adamska, Agnieszka, et al.
Publicado: (2020)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis
por: Yuwen, Tianyi, et al.
Publicado: (2023)

SUN-008 Loss of Antimullerian Hormone Immunoreactivity Due to a Homozygous AMH Gene Mutation Rs10417628 in a Woman with Classical Polycystic Ovary Syndrome
por: Hoyos, Luis R, et al.
Publicado: (2020)

Role of AMH in Prediction of Menopause
por: de Kat, Annelien C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1fu4kbf3qrvqr9qnj40p6hd7u